In addition, investigators demonstrated that GPC2 is required for neuroblastoma proliferation and developed a GPC2-targeting antibody-drug conjugate with significant cytotoxicity against highly expressing GPC2 neuroblastoma cells [9]. This evidence concerns the gene GPC2 and neuroblastoma.